# Quantitative Portfolio Analysis & Optimization

## Overview
A comprehensive portfolio optimization project applying Modern Portfolio Theory (MPT) to construct two distinct investment strategies: a direct equity portfolio and a mutual fund portfolio. The project demonstrates quantitative finance principles, statistical analysis, and risk-return optimization techniques to maximize Sharpe ratios through data-driven asset allocation.

## ğŸ¯ Objective
To construct optimal portfolios that maximize risk-adjusted returns using mathematical optimization, moving beyond naive equal-weighting strategies to achieve superior performance through statistical analysis of historical data.

## ğŸ“Š Project Structure

### Dual Portfolio Strategy
- **Equity Portfolio**: 4 individual stocks across diverse sectors
- **Mutual Fund Portfolio**: 4 professionally managed funds with varied strategies

### Methodology Framework
1. **Fundamental Analysis**: Comprehensive evaluation of each investment vehicle
2. **Statistical Modeling**: Historical return analysis and covariance calculation
3. **Optimization**: Sharpe ratio maximization using Excel Solver
4. **Validation**: Backtesting with recent market data

## ğŸ¢ Investment Universe

### Equity Portfolio
| Company | Sector | Market Cap | Key Rationale |
|---------|--------|------------|---------------|
| **HDFC Bank** | Banking | â‚¹15.2L Cr | Market leadership, superior asset quality |
| **Divi's Laboratories** | Pharmaceuticals | â‚¹1.8L Cr | Global API dominance, regulatory compliance |
| **Bharat Dynamics** | Defense | â‚¹72K Cr | Defense indigenization beneficiary |
| **Jubilant FoodWorks** | QSR/Food Services | â‚¹47K Cr | Dominant pizza market position |

### Mutual Fund Portfolio
| Fund | Category | Strategy | AUM Focus |
|------|----------|----------|-----------|
| **Parag Parikh Flexi Cap** | Multi-cap | Value + International exposure | Core holding |
| **DSP Healthcare** | Sectoral | Healthcare/Pharma focused | Thematic play |
| **Mirae Asset NYSE FANG+ ETF** | International | US Tech giants | Growth/Tactical |
| **Tata Banking & Financial Services** | Sectoral | BFSI proxy | Economic growth play |

## ğŸ”¬ Technical Methodology

### Statistical Analysis
- **Covariance Matrix Calculation**: Quantified inter-asset correlations
- **Risk-Return Profiling**: Analyzed historical volatility and returns
- **Sharpe Ratio Optimization**: Maximized (Return - Risk-free rate) / Volatility

### Optimization Process
```
1. Data Collection â†’ Daily price data (252+ trading days)
2. Return Calculation â†’ Daily returns matrix
3. Covariance Analysis â†’ Risk relationship mapping
4. Constraint Setting â†’ Weights sum to 1, no short selling
5. Solver Optimization â†’ Maximum Sharpe ratio objective
6. Weight Allocation â†’ Optimal portfolio composition
```

## ğŸ“ˆ Key Results

### Equity Portfolio Performance
- **Equal Weight Baseline**: Sharpe Ratio 2.09, Return 49.49%, Volatility 20.76%
- **Optimized Portfolio**: Sharpe Ratio 2.28, Return 54.01%, Volatility 21.04%
- **Improvement**: 9.1% enhancement in risk-adjusted returns

#### Optimal Allocation
- Divi's Laboratories: 36.90%
- Jubilant FoodWorks: 28.73%
- HDFC Bank: 21.59%
- Bharat Dynamics: 12.77%

### Mutual Fund Portfolio Performance
- **Equal Weight Baseline**: Sharpe Ratio 1.23, Return 23.26%, Volatility 14.01%
- **Optimized Portfolio**: Sharpe Ratio 1.28, Return 25.83%, Volatility 15.48%
- **Improvement**: 4.1% enhancement in risk-adjusted returns

#### Optimal Allocation
- Parag Parikh Flexi Cap: 41.68%
- Mirae Asset NYSE FANG+: 37.65%
- DSP Healthcare: 15.64%
- Tata Banking & Financial: 5.03%

## ğŸ” Key Insights

### Portfolio Construction Learnings
- **Diversification Benefits**: Mathematical optimization revealed non-intuitive weight allocations
- **Risk-Return Tradeoffs**: Higher-returning assets didn't always receive highest weights due to correlation effects
- **Sector Concentration**: Defensive sectors (banking) balanced growth sectors (pharma, defense)

### Validation Results
- Backtesting confirmed theoretical optimization improvements
- Short-term performance exceeded long-term projections (characteristic of favorable market conditions)
- Model assumptions (i.i.d. returns) held reasonably well in testing period

## âš ï¸ Limitations & Assumptions

### Model Limitations
- **Historical Bias**: Past performance doesn't guarantee future results
- **Market Regime Changes**: Fixed covariance assumes stable market relationships
- **Transaction Costs**: Real-world implementation costs not considered
- **Liquidity Constraints**: Assumes perfect divisibility and liquidity

### Methodological Assumptions
- Daily returns are independently and identically distributed
- Risk-free rate remains constant
- No leverage or short selling constraints
- Static optimization (no rebalancing strategy)

## ğŸ› ï¸ Tools & Technologies
- **Excel**: Primary analysis platform with Solver optimization
- **Statistical Functions**: Covariance, correlation, and performance calculations
- **Financial Modeling**: DCF valuation, ratio analysis, peer comparisons
- **Data Sources**: Historical market data, financial statements

## ğŸ“ File Structure
```
ğŸ“ Portfolio-Optimization-Project/
â”œâ”€â”€ ğŸ“„ README.md
â”œâ”€â”€ ğŸ“Š Portfolio-analysis.xlsx
â”‚   â”œâ”€â”€ ğŸ“‹ Landing Page
â”‚   â”œâ”€â”€ ğŸ“ˆ Stock Equal Weights
â”‚   â”œâ”€â”€ ğŸ“ˆ Stocks Optimized Weights  
â”‚   â”œâ”€â”€ ğŸ“ˆ Stock Backtesting
â”‚   â”œâ”€â”€ ğŸ“ˆ MF Equal/Optimized/Backtesting
â”‚   â””â”€â”€ ğŸ“‹ Individual Company Analysis Sheets
â””â”€â”€ ğŸ“„ Report-on-portfolio-analysis.pdf
```


## ğŸ”— Applications
This methodology framework can be extended to:
- **Asset Management**: Professional portfolio construction
- **Risk Management**: Quantitative risk assessment
- **Financial Planning**: Individual investment optimization
- **Research**: Academic finance and behavioral studies

## ğŸ“ Future Enhancements
- Dynamic rebalancing strategies
- Multi-period optimization models
- Alternative risk measures (VaR, CVaR)
- Machine learning integration for return prediction
- ESG factor incorporation

## Sources of Data
- https://www.screener.in/
- https://www.bloomberg.com/

---

**Note**: This project demonstrates academic application of quantitative finance principles. All investment analysis is for educational purposes and should not be considered as investment advice.
